Does Trazodone Make It Hard to Wake Up?

Trazodone is one of the most commonly prescribed medications for insomnia in the United States, and morning grogginess is its most frequent side effect. Somewhere between a quarter and two-fifths of people who take it report drowsiness or sedation that can linger into the next day. The effect is dose-dependent, meaning the higher your dose, the more likely you are to struggle with waking up and feeling alert in the morning. But the story is more interesting than a simple “yes, it makes mornings harder,” because how trazodone reshapes your sleep architecture, what it does to your cognitive sharpness the next day, and who faces the greatest risks all matter for understanding your own experience with the drug.

Why Trazodone Causes Sedation in the First Place

Trazodone was originally developed as an antidepressant, and it still carries that label. But at the lower doses typically prescribed for sleep, its sedating properties dominate. The drug blocks histamine receptors and certain serotonin receptors in the brain, both of which play roles in keeping you awake and alert. At antidepressant doses (150 to 300 mg or more), its mood-lifting effects become more prominent. At the lower doses used for insomnia (25 to 100 mg), sedation is front and center because the histamine-blocking effect kicks in at lower concentrations than the antidepressant mechanisms do.

This is why drowsiness is described as dose-dependent: higher doses produce more sedation, but even low doses produce enough to help people fall asleep. A systematic review of the available evidence confirmed that drowsiness is the most common side effect of trazodone and that it scales with the dose taken.1PubMed Central. Trazodone for Insomnia: A Systematic Review The clinical incidence of drowsiness and sedation runs between about 24 and 41 percent of patients, and it tends to be most pronounced during the first days and weeks of treatment.2Psychopharmacology Institute. Trazodone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects Some of that sedation wears off with continued use as your body adjusts, but for many people it never fully disappears, and it spills over into morning hours.

How Trazodone Reshapes Your Sleep

Trazodone does not simply knock you out. It changes the internal structure of your sleep in ways that help explain both why people feel like they sleep better on it and why mornings can feel sluggish. One of its most consistent effects is increasing the time you spend in deep sleep, the slow-wave stages that your body uses for physical restoration. A study using polysomnography (the kind of sleep test done with electrodes in a lab) found that trazodone roughly doubled the amount of time participants spent in deep sleep while cutting the number of times they woke up during the night in half.3PubMed Central. Trazodone enhances sleep in subjective quality but not in objective duration

A more recent meta-analysis that pooled data across multiple studies found that trazodone increased total sleep time by about 40 minutes on average and significantly boosted the deep-sleep stage compared to placebo.4Scientific Reports. Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis That deeper, more consolidated sleep is a genuine benefit, and it is the reason patients consistently rate their sleep quality as improved on trazodone. Compared to common sleeping pills like benzodiazepines and Z-drugs, trazodone actually preserves and enhances slow-wave activity rather than suppressing it, which is a meaningful distinction in terms of sleep quality.5Psychiatria Polska. Treatment of insomnia – effect of trazodone and hypnotics on sleep

Here is the catch: being pulled deeper into slow-wave sleep can make it harder to wake up. If your alarm goes off while you are in the deepest sleep stages, you experience more sleep inertia, that heavy, disoriented feeling when you first open your eyes. Trazodone is essentially making your sleep “stickier” by keeping you in the restorative stages longer. That is good for sleep quality but can be genuinely annoying when your alarm demands you get moving.

The Subjective Sleep Quality Puzzle

An interesting wrinkle is that trazodone’s reputation for improving sleep may be partly about perception. The same polysomnographic study that documented the increase in deep sleep also found that trazodone enhanced how good participants felt their sleep was without actually increasing the total objective duration of sleep by a significant amount.3PubMed Central. Trazodone enhances sleep in subjective quality but not in objective duration In other words, people slept about the same total hours but woke up feeling like they had slept much better. This makes sense given the shift toward deeper sleep and fewer middle-of-the-night awakenings. But it also means the morning grogginess is not coming from sleeping too long; it is a pharmacological hangover, the drug still lingering in your system as the new day starts.

Trazodone’s half-life is roughly five to nine hours in most adults, meaning the drug is still active in your bloodstream when your morning alarm sounds if you took it at bedtime. Younger, healthier livers clear it faster. Older adults, people taking other medications that slow liver enzymes, or those on higher doses will have more of the drug still circulating at dawn. That lingering drug presence is the primary reason some people feel like they are wading through mud for the first hour or two after waking.

Next-Day Cognitive and Physical Effects

Morning grogginess from trazodone is not just a feeling; it shows up on objective tests. A controlled trial in people with primary insomnia measured cognitive and physical performance during trazodone treatment. The study found small but statistically significant impairments in short-term memory, verbal learning, balance, and arm muscle endurance across the testing period.6PubMed Central. Cognitive, Psychomotor, and Polysomnographic Effects of Trazodone in Primary Insomniacs These are the kinds of effects you would notice as feeling mentally foggy, having trouble remembering names, or being slightly unsteady on your feet first thing in the morning.

One reassuring finding from the same study: driving performance on a simulated driving test was not significantly impaired by trazodone, and there was no increase in speeding errors.6PubMed Central. Cognitive, Psychomotor, and Polysomnographic Effects of Trazodone in Primary Insomniacs That does not mean you should assume it is completely safe to drive first thing in the morning while still feeling groggy, but it does suggest that the cognitive impairments are at the milder end of the spectrum compared to some other sedating medications. The effects tend to be most noticeable during the first week or so, when your body has not yet adjusted to the drug.

For people taking trazodone at antidepressant doses (150 mg and above), these next-day effects are generally more pronounced. If you are on a low dose for sleep and still finding mornings difficult after the first couple of weeks, it is worth talking to your prescriber about adjusting the dose or the timing.

Practical Strategies for Easier Mornings

If trazodone is helping your insomnia but making mornings miserable, there are several adjustments that can help before you give up on the medication entirely.

  • Take it earlier: Most people take trazodone right at bedtime, but taking it 30 to 60 minutes before you actually want to fall asleep gives the drug a head start. More of it will be metabolized by morning.
  • Lower the dose: Because the sedation is dose-dependent, even a small reduction can make a noticeable difference in morning alertness. Some people do well on as little as 25 mg.
  • Watch for drug interactions: Anything else you take that slows your liver’s CYP3A4 enzyme pathway can effectively increase the amount of trazodone in your system. Common culprits include certain antifungal medications, some antibiotics, and grapefruit juice. If you recently added a new medication and mornings got worse, that interaction might be the reason.
  • Give it time: The sedating effect is typically strongest during the first one to two weeks of treatment. Many people find that the morning grogginess improves, though it may not vanish entirely.
  • Light and movement: Bright light exposure and physical activity in the morning help counteract sleep inertia from any cause. Opening curtains immediately or stepping outside for a few minutes can accelerate the wake-up process.

Alcohol deserves a specific mention. Combining trazodone with even moderate amounts of alcohol intensifies sedation and makes the morning hangover dramatically worse. If you are having trouble waking up on trazodone, checking your evening alcohol intake is one of the simplest things to address.

Older Adults Face Greater Risks

The difficulty-waking-up problem takes on a different character in older adults. For people over 65, the concern is not just grogginess but safety. Trazodone causes drops in blood pressure when you stand up, a phenomenon called orthostatic hypotension. In younger people this is usually a brief dizzy spell. In older adults, especially those already taking blood pressure medications, it can lead to fainting and falls.

A recent study of older outpatients with high blood pressure found that trazodone users had significantly greater drops in both systolic and diastolic blood pressure upon standing compared to non-users. Over the follow-up period, the incidence of fainting episodes and falls was dramatically higher in the trazodone group, about 58 percent compared to 21 percent in the control group. This increased risk held up even after accounting for age, physical fitness, disability, and how many blood pressure medications someone was taking.7PubMed Central. Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension

For an older adult, “hard to wake up” can mean more than mental fog. It can mean standing up from bed, feeling lightheaded, and falling. The combination of residual sedation, impaired balance (which the cognitive-performance study documented), and blood pressure drops makes the transition from sleep to standing genuinely dangerous for this population. If you are an older adult on trazodone, or if you are helping care for one, the morning routine matters. Sitting on the edge of the bed for a minute or two before standing, keeping a glass of water on the nightstand, and making sure the path from bed to bathroom is clear and well-lit are not trivial suggestions; they are fall-prevention measures supported by the data.

How Trazodone Compares to Other Sleep Medications

Trazodone is not the only sleep medication that causes morning grogginess, and understanding where it sits relative to alternatives helps put the problem in context. The Z-drugs (zolpidem, eszopiclone, zaleplon) are the other major category of medications prescribed for insomnia. Both drug classes carry side-effect profiles that include drowsiness, dizziness, and cognitive and motor impairment that can increase fall and fracture risk.8PubMed Central. Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis

Where trazodone has an edge is in what it does to sleep architecture. As noted earlier, trazodone increases deep sleep, while most traditional hypnotics and Z-drugs actually suppress slow-wave activity.5Psychiatria Polska. Treatment of insomnia – effect of trazodone and hypnotics on sleep This means that even though both classes of drug can leave you groggy in the morning, the sleep you got on trazodone was physiologically more restorative. You might feel drowsy upon waking, but the sleep itself did your brain and body more good. For chronic insomnia in particular, this is a meaningful trade-off, since the goal is not just to fall asleep but to sleep in a way that actually restores function.

Trazodone also does not carry the same dependence risk as benzodiazepines or Z-drugs. You can develop tolerance to its sedating effects to some degree, but physical dependence and withdrawal syndromes are far less common. For people who need a sleep aid they can use for months or years, this matters. The morning grogginess may be the price of a medication that is safer for long-term use.

Extended-Release Formulations

If you have heard that extended-release trazodone might solve the morning problem, the reality is mixed. Extended-release formulations exist primarily for use at antidepressant doses, not for insomnia. They release the drug more slowly, which should in theory smooth out the sedation curve and reduce peak drowsiness. In a randomized trial of extended-release trazodone for depression, somnolence was still one of the two most commonly reported side effects, alongside headache.9PubMed Central. Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study

The slow-release design spreads the drug’s effects over a longer period, which can actually make morning sedation worse rather than better in some cases, since more of the drug is still being released at wake time. For insomnia specifically, the standard immediate-release tablet taken early enough in the evening is generally the better fit. Extended-release may make sense for people who are taking trazodone for depression and want some sleep benefit, but it is not a straightforward fix for the morning grogginess problem.

When You Stop Taking Trazodone

If morning grogginess eventually pushes you to discontinue trazodone, the transition itself can temporarily affect your sleep. The polysomnographic study that documented trazodone’s boost to deep sleep also found a negative rebound after the drug was withdrawn: deep sleep dropped back and REM sleep rebounded above baseline levels.3PubMed Central. Trazodone enhances sleep in subjective quality but not in objective duration In plain terms, you may have a few nights of lighter, more dream-heavy sleep after stopping, and your overall sleep quality may feel temporarily worse than it did before you ever started the medication.

This rebound is not dangerous and typically resolves within a week or two, but it is worth knowing about so you do not interpret it as proof that you “need” the drug. If you were taking trazodone at higher doses or for a long period, tapering gradually rather than stopping abruptly is generally the better approach. Your prescriber can help you set up a tapering schedule that minimizes sleep disruption during the transition. The existence of this rebound does not mean trazodone is addictive in the way benzodiazepines are; it is more like your brain readjusting its sleep patterns after the drug’s influence is removed.

Individual Variation Is Real

One of the frustrating things about trazodone is the wide range of individual responses. Some people take 50 mg and feel perfectly sharp by 7 a.m. Others take 25 mg and cannot function until noon. Part of this comes down to genetics, specifically how efficiently your liver metabolizes the drug. The primary enzyme responsible for breaking down trazodone (CYP3A4) varies in activity across the population. People who are naturally slow metabolizers will have more drug in their system at any given time, leading to stronger and longer-lasting sedation.

Body weight, age, kidney and liver function, other medications, and even what you ate for dinner all play roles in how quickly trazodone clears your system. Women tend to have slightly different pharmacokinetics than men for many drugs processed through CYP3A4, though the clinical significance of this for trazodone specifically has not been studied in large enough detail to make firm statements. The practical upshot is that if you are finding mornings impossible, a dose that works perfectly for a friend or family member may not be the right dose for you. Trazodone dosing for insomnia is more art than science, and finding the sweet spot between good sleep and tolerable mornings often takes some trial and adjustment.

Elena Thatcher

Elena Thatcher holds an MSc in pharmaceutical sciences from the University of Toronto. She has worked in medical communications and health publishing for 11 years, specializing in pharmacology and clinical trial data. Her subject expertise includes biologics, biosimilars and generic drugs.